Alpha Cognition Inc. Files S-1/A Amendment
Ticker: ACOG · Form: S-1/A · Filed: May 22, 2024 · CIK: 1655923
Sentiment: neutral
Topics: sec-filing, registration-statement, amendment
TL;DR
Alpha Cognition Inc. (ALPH) filed an S-1/A amendment on 5/22. Looks like they're still prepping for a public offering.
AI Summary
Alpha Cognition Inc. filed an S-1/A amendment on May 22, 2024, for its registration statement (No. 333-278997). The company, formerly known as Neurodyn Cognition Inc. until October 16, 2015, is incorporated in British Columbia and operates in the Biological Products sector. Its principal executive offices are located in Vancouver, BC, with a business phone number of (858) 344-4375.
Why It Matters
This filing indicates Alpha Cognition Inc. is actively pursuing a public offering or other securities-related actions, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: medium — S-1/A filings often precede significant corporate events like stock offerings, which carry inherent market risks.
Key Numbers
- 333-278997 — Registration Number (Identifies the specific SEC registration for this filing.)
- 20240522 — Filing Date (The date the amendment was officially filed with the SEC.)
Key Players & Entities
- Alpha Cognition Inc. (company) — Registrant
- 333-278997 (dollar_amount) — Registration Number
- May 22, 2024 (date) — Filing Date
- Neurodyn Cognition Inc. (company) — Former Company Name
- October 16, 2015 (date) — Date of Name Change
- Michael McFadden (person) — Chief Executive Officer
FAQ
What is the primary purpose of this S-1/A filing?
This S-1/A filing is an amendment to a registration statement, typically indicating the company is updating information related to a planned securities offering or other regulatory requirements.
When was Alpha Cognition Inc. formerly known by another name?
Alpha Cognition Inc. was formerly known as Neurodyn Cognition Inc. until October 16, 2015.
What is the SIC code for Alpha Cognition Inc.?
The Standard Industrial Classification (SIC) code for Alpha Cognition Inc. is 2836, which corresponds to Biological Products (NO DIAGNOSTIC SUBSTANCES).
Who is the CEO of Alpha Cognition Inc.?
Michael McFadden is the Chief Executive Officer of Alpha Cognition Inc.
Where are Alpha Cognition Inc.'s principal executive offices located?
Alpha Cognition Inc.'s principal executive offices are located at 1200 - 750 West Pender Street, Vancouver, BC, V6C 2T8.
Filing Stats: 4,233 words · 17 min read · ~14 pages · Grade level 15.4 · Accepted 2024-05-22 16:26:12
Key Financial Figures
- $0 — ce of our common shares on the CSE was C$0. 70 and the last quoted price of our co
- $13.5B — e impairment with mild TBI would have a $13.5B market size (1.1M cases per yr X assumi
- $12.5K — et size (1.1M cases per yr X assuming a $12.5K per treatment course) in the US. 
Filing Documents
- ea0201255-07.htm (S-1/A) — 9100KB
- ea020125507ex23-1_alpha.htm (EX-23.1) — 2KB
- talpha_logo.jpg (GRAPHIC) — 151KB
- timage_001.jpg (GRAPHIC) — 559KB
- timage_002.jpg (GRAPHIC) — 359KB
- timage_003.jpg (GRAPHIC) — 384KB
- timage_004.jpg (GRAPHIC) — 417KB
- timage_005.jpg (GRAPHIC) — 379KB
- timage_006.jpg (GRAPHIC) — 761KB
- timage_007.jpg (GRAPHIC) — 364KB
- timage_009.jpg (GRAPHIC) — 180KB
- theader_001.jpg (GRAPHIC) — 103KB
- ex23-1_001.jpg (GRAPHIC) — 16KB
- 0001213900-24-045921.txt ( ) — 14164KB
RISK FACTORS
RISK FACTORS   18 MARKET PRICE INFORMATION AND DIVIDEND POLICY   74
USE OF PROCEEDS
USE OF PROCEEDS   75
BUSINESS
BUSINESS   76 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   101 DESCRIPTION OF PROPERTIES   119 DIRECTORS, OFFICERS AND CERTAIN SIGNIFICANT EMPLOYEES   120
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION   128 PRINCIPAL STOCKHOLDERS   133 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS   135
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK   136 PLAN OF DISTRIBUTION   145 DESCRIPTION OF PRIVATE PLACEMENT   147 SELLING STOCKHOLDERS   148 MATERIAL FEDERAL INCOME TAX CONSIDERATIONS   157 LEGAL MATTERS   166 EXPERTS   166 WHERE YOU CAN FIND MORE INFORMATION   166 INDEX TO FINANCIAL STATEMENTS   F-1 i Table of Contents ABOUT THIS PROSPECTUS We are responsible for the information contained in this prospectus and in any free -writing prospectus we have authorized. We have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you and which we have filed with the U.S. Securities and Exchange Commission (the “ SEC ”). We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the common shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this prospectus is current only as of the date on the front cover of the prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside the United States: We have not done anything that would permit the resale of the common shares under this prospectus or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the Unite